Matthew Judson is a research associate in the UNC Neuroscience Center at the University of North Carolina at Chapel Hill.
Matthew Judson
Research associate
University of North Carolina at Chapel Hill
From this contributor
Angelman syndrome: Bellwether for genetic therapy in autism
It is not a matter of whether there will be clinical trials of genetic therapy for Angelman syndrome, but when.
Angelman syndrome: Bellwether for genetic therapy in autism
Insights for autism from Angelman syndrome
Deletions or duplications of the UBE3A gene lead to both Angelman syndrome and some cases of autism, respectively. Studying the effects of altered gene dosage in this region will provide insights into brain defects and suggest targets for therapies for both disorders, says expert Benjamin Philpot.
Insights for autism from Angelman syndrome
Explore more from The Transmitter
Stress warps fear memories in multiple ways
Expanding the bounds of a fear memory or linking it to a neutral memory can shape a mouse’s fear response, two new studies show.
Stress warps fear memories in multiple ways
Expanding the bounds of a fear memory or linking it to a neutral memory can shape a mouse’s fear response, two new studies show.
How to be a multidisciplinary neuroscientist
Neuroscience subfields are often siloed. Embracing an integrative approach during training can help change that.
How to be a multidisciplinary neuroscientist
Neuroscience subfields are often siloed. Embracing an integrative approach during training can help change that.
Newfound gene network controls long-range connections between emotional, cognitive brain areas
The finding could help unravel gene regulatory networks and explain how genetic and environmental factors interact in neurodevelopmental conditions.
Newfound gene network controls long-range connections between emotional, cognitive brain areas
The finding could help unravel gene regulatory networks and explain how genetic and environmental factors interact in neurodevelopmental conditions.